Riou, M.; Oulehri, W.; Momas, C.; Rouyer, O.; Lebourg, F.; Meyer, A.; Enache, I.; Pistea, C.; Charloux, A.; Marcot, C.;
et al. Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection. J. Clin. Med. 2021, 10, 1318.
https://doi.org/10.3390/jcm10061318
AMA Style
Riou M, Oulehri W, Momas C, Rouyer O, Lebourg F, Meyer A, Enache I, Pistea C, Charloux A, Marcot C,
et al. Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection. Journal of Clinical Medicine. 2021; 10(6):1318.
https://doi.org/10.3390/jcm10061318
Chicago/Turabian Style
Riou, Marianne, Walid Oulehri, Cedric Momas, Olivier Rouyer, Fabienne Lebourg, Alain Meyer, Irina Enache, Cristina Pistea, Anne Charloux, Christophe Marcot,
and et al. 2021. "Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection" Journal of Clinical Medicine 10, no. 6: 1318.
https://doi.org/10.3390/jcm10061318
APA Style
Riou, M., Oulehri, W., Momas, C., Rouyer, O., Lebourg, F., Meyer, A., Enache, I., Pistea, C., Charloux, A., Marcot, C., de Blay, F., Collange, O., Mertes, M., Andrès, E., Talha, S., & Geny, B.
(2021). Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection. Journal of Clinical Medicine, 10(6), 1318.
https://doi.org/10.3390/jcm10061318